SUMMARY Subacute combined degeneration of the cord is a rare complication of folate deficiency. Disturbance of methylation reactions in nervous tissue probably underlie subacute combined degeneration of the cord arising from folate as well as vitamin B12 deficiency. Methyl tetrahydrofolate is the form in which folic acid is transported into the CNS. Therefore methyl tetrahydrofolate treatment of the neurological and psychiatric manifestations of folate deficiency would seem to be theoretically advantageous. A case of subacute combined degeneration of the cord due to dietary folate deficiency and associated with an organic brain syndrome is reported. There was striking haematological, neurological and psychiatric response to methyl folate treatment.
Subacute combined degeneration of the spinal cord is a rare complication of folate deficiency. In a review of 25 previously reported cases' prior to 1979 five met the following criteria:-pyramidal and dorsal column signs, low serum and red cell (or CSF) folate, megaloblastic marrow, normal vitamin B12 levels of absorption, and reversibility of neurological signs by folate, but not vitamin B12 (table 1) . Histopathological confirmation of subacute combined degeneration of the cord due to folate deficiency has been reported since then in an alcoholic,2 and in a child with pure folate deficiency due to an inborn error of folate metabolism as a result of methylene tetrahydrofolate reductase deficiency.3
Methyl folate is the reduced form of folate in blood. Separate transport mechanisms exist for the transport of reduced and non-reduced folates into intestinal cells.4 Transport of reduced folate is active, energy-dependent, and carrier-mediated and several fold greater than that of non-reduced folates. Folic acid crosses the blood brain barrier as methyl tetrahydrofolate by an active process,5 and is present in CSF in man in concentrations three times greater than plasma.6 Treatment of folate deficiency-induced neuropsychiatric disorders by methyl folate, the transport form of folate into the nervous system, would thus appear to be theoretically advantageous.
We describe a case of subacute combined degeneration of the cord due to folate deficiency which responded to treatment with methyl,folate. In addition the patient had an organic brain syndrome which also responded in part to methyl folate therapy.
Case report JD, a 53-year-old woman, presented with a 2 year history of progressive leg weakness, paraesthesiae of hands and feet, dyspnoea on -exertion, and six months confusion. She had a 15 year history of alcohol abuse and 10 years of intermittent depression. Two years previously she had been investigated for lethargy and had been noted to have spider naevi and liver palms, an MCV of 105, and normal serum folate and vitamin B12 levels. On examination she was anaemic, apathetic, confused, with poor concentration, and confabulating. She was disoriented in time and place. She had horizontal nystagmus, an ataxic broad based gait, symmetrical grade 3 pyramidal weakness of her legs, absent knee and ankle reflexes and bilateral extensor plantar responses.
Investigations confirmed she had a macrocytic anaemia: Hb 9 gm/dl, MCV 126, with a megaloblastic marrow. Serum vitamin B12 on admission was 775ng/l (N 200-800) but serum folate (07 ng/ml), red cell folate (68 ng/ml) (N200-800) and CSF folate 5 ng/ml (N > 15) were all very low. CSF S-adenosyl-methionine (SAM) was 37-7 ng/ml (control range 35-90. The control range is derived from a study of 24 severely depressed patients 25% of whom also had severe folate deficiency. The mean for the group was 55 Electrophysiological studies (Dr J Payan) revealed that surface recorded sural nerve potentials had an amplitude of 5 ,V, which is half the normal minimum for this laboratory.
The median nerve sensory potential recorded at the wrist on stimulating the middle finger was only 7 pV, which was less than half our normal minimum and smaller than the corresponding ulnar potential (8 pV). This reversal of the normal relationship almost certainly reflected added local median nerve damage at the wrist, for the distal motor latency to thenar muscles was increased (4 7 ms, normal does not exceed 4 0 ms; hypothenar potential latency in this case 3 1 ms). Moreover, the median mixed nerve potential recorded at the elbow was markedly reduced (4pV, normal minimum 20 1V; ulnar mixed potential in this case 27 pV, normal minumum 30 ,V). The amplitude and form of evoked muscle potentials was normal, but the hypothenar potential was 25% smaller on stimulating above the elbow than at the wrist. The abductor hallucis potential had a slightly increased F wave latency (59 ms). In brief, nerve conduction studies show a mild mixed, predominantly sensory, polyneuropathy of axonal type with added damage, as is common, to the median nerve at the wrist and the ulnar nerve at the elbow.
Investigations to exclude other causes of myelopathy were performed. Serum The psychiatric response to methyl folate in our patient should be interpreted with caution. She clearly had more than one deficiency state and had initially received both parenterovite and vitamin B12. Certainly the early improvement in her mental state especially her initial confusion was due at least in part to repletion of thiamine as well as dietary factors, including folate. However one month after thiamine and vitamin B12 therapy she remained flat, apathetic and globally impaired and the subsequent rapid change in mood and cognition after methyl folate strongly suggested that a large contribution of her residual organic mental impairment was due to severe folate deficiency. This is supported by a number of lines of evidence. Studies of neuropsychiatric and geriatric patients have linked severe folate deficiency to organic mental states, especially endogenous depression.15 16 Inborn errors of folate metabolism are associated with mental retardation,' 7 and methotrexate, a tetrahydrofolate reductase inhibitor, has been reported to cause acute organic mental disturbance.18 It is interesting that in this patient CSF SAM level was initially low and increased slightly but significantly following two weeks of methyl folate in association with impressive changes in mood and cognition. Recent studies have shown improvement in mood following SAM therapy in some patients with endogenous depression.'9 20
The role of alcohol should also be considered. Firstly the patient was an alcoholic on a folate deficient diet similar to four out of the six previous reports summarised in the The possibility of an alcohol-related myelopathy associated with natural or artificial portosystemic shunts was considered. However this myelopathy is characterised by spastic tone, hyperreflexia and flexor plantars.31 In our patient tone was normal, knees and ankle reflexes were initially absent and plantars were extensor. Moreover there was no splenomegaly, varices or ascites and the impressive recovery of the myelopathy would also be against such an interpretation.
In view of the frequency of folate deficiency in alcoholic patients, the role of this vitamin in the neuropsychiatric disorders of alcoholism would repay further study. There is also evidence in the rat that pure folate deficiency leads to malabsorption of thiamine. 
